In idiopathic Parkinson's disease, intracytoplasmic neuronal inclusions (Lewy bodies) containing aggregates of the protein ␣-synuclein (␣S) are deposited in the pigmented nuclei of the brainstem. The mechanisms underlying the structural transition of innocuous, presumably natively unfolded, ␣S to neurotoxic forms are largely unknown. Using paramagnetic relaxation enhancement and NMR dipolar couplings, we show that monomeric ␣S assumes conformations that are stabilized by long-range interactions and act to inhibit oligomerization and aggregation. The autoinhibitory conformations fluctuate in the range of nanoseconds to microseconds corresponding to the time scale of secondary structure formation during folding. Polyamine binding and͞or temperature increase, conditions that induce aggregation in vitro, release this inherent tertiary structure, leading to a completely unfolded conformation that associates readily. Stabilization of the native, autoinhibitory structure of ␣S constitutes a potential strategy for reducing or inhibiting oligomerization and aggregation in Parkinson's disease.is the second most common neurodegenerative disease and the most common movement disorder, affecting 1-2% of the population over 65 years of age (1). The cause of PD is as yet unclear due in part to a complex etiology involving a combination of genetic susceptibility and numerous environmental factors (2). Proteinaceous aggregates in motor neurons of the substantia nigra and locus coeruleus are characteristic of idiopathic PD. An abundant component of these so-called Lewy bodies is the presynaptic protein ␣-synuclein (␣S) (3). Three genetic mutations in ␣S (A30P, E46K and A53T) have been identified in autosomal-dominantly inherited early-onset PD (4, 5). In vitro, different conditions such as increased temperature, lower pH, and naturally occurring polyamines accelerate ␣S aggregation (6, 7). Compelling evidence now supports a cytotoxic role in PD for protofibrils, early oligomers of ␣S (8).In other amyloid-related neurological disorders, such as Creutzfeldt-Jakob disease, protein oligomerization͞aggregation requires destabilization of a soluble monomeric protein followed by the formation of highly ordered, -sheet-like fibrillar structures (9). ␣S, however, belongs to the class of natively unfolded proteins with no apparent ordered secondary structure detectable by far-UV CD, Fourier transform IR, or NMR spectroscopy (6, 10, 11), although recent evidence indicates the existence of distinct, functionally relevant intramolecular interactions (refs. 7 and 12 and this work). The challenge is to rationalize in structural terms the inactive state of the soluble, unstructured protein and the potentiation of aggregation by point mutations, ligand binding, or changes in solution conditions. During the past decade numerous NMR techniques have been developed for elucidating the unfolded states of proteins in atomic detail (13). 15 N-relaxation time measurements and paramagnetic relaxation enhancement (PRE) from site-directed spin labeling allo...
␣-Synuclein (␣-syn) phosphorylation at serine 129 is characteristic of Parkinson disease (PD) and related ␣-synulceinopathies. However, whether phosphorylation promotes or inhibits ␣-syn aggregation and neurotoxicity in vivo remains unknown. This understanding is critical for elucidating the role of ␣-syn in the pathogenesis of PD and for development of therapeutic strategies for PD. To better understand the structural and molecular consequences of Ser-129 phosphorylation, we compared the biochemical, structural, and membrane binding properties of wild type ␣-syn to those of the phosphorylation mimics (S129E, S129D) as well as of in vitro phosphorylated ␣-syn using a battery of biophysical techniques. Our results demonstrate that phosphorylation at Ser-129 increases the conformational flexibility of ␣-syn and inhibits its fibrillogenesis in vitro but does not perturb its membrane-bound conformation. In addition, we show that the phosphorylation mimics (S129E/D) do not reproduce the effect of phosphorylation on the structural and aggregation properties of ␣-syn in vitro. Our findings have significant implications for current strategies to elucidate the role of phosphorylation in modulating protein structure and function in health and disease and provide novel insight into the underlying mechanisms that govern ␣-syn aggregation and toxicity in PD and related ␣-synulceinopathies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.